With the AACR abstract drop coming tomorrow, it’s a good opportunity to explore what are some of the important broader themes to watch out for at the annual meeting this year?

In the first of our conference preview series, we highlight six key areas to watch out for and why they’re important in the context of novel or early stage development molecules coming through in oncology pipelines.

Some of the selections may well cause a few surprises…

To continue reading our latest highlights on oncology new product development including commentary and analysis BSB subscribers can log-in or you can click to access the content.

This content is restricted to subscribers

Posted by